glp-1 gip news Five-target drug beats GLP-1/GIP therapy in obese diabetic mice Twincretin drug Tirzepatide shows unmatched

The other thing were seeing is a lot of companies getting really excited about this idea of helping people who are not on these drugs or are coming off the drugs and needing to control their appetite. Supergut: Interest off the charts following Natures Ozempic positioning One company currently capitalizing on a surge of consumer interest in natural alternatives to GLP-1 drugs is Supergut (formerly Muniq), a startup making bars and shakes containing a blend of resistant starches and prebiotic fibers that are fermented in the gut to produce short chain fatty acids

Who should use GLP-1 Medications

The 2005 Bissett, Oblong, and Berge follow-up in Dermatologic Surgery added cutometric elasticity improvements to the measured outcomes [14]

It also has been found to have anti-inflammatory effects in various tissues